BIOLIT ApS: Financial statements 2022
CVR: 10068460
Source: annual report 2022, Danish Business Authority
01/06/2021 – 31/05/2022
BIOLIT ApS (CVR 10068460) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 2,382,658 and a net result of DKK 3,164,066 compared with DKK 1,567,561 the year before. That is an increase of 30.3% compared with the year before. Equity in the 2022 report amounted to DKK 13,550,280. The solvency ratio was 61.5%.
- Gross Profit
- DKK 2,382,658
- Profit/Loss
- DKK 3,164,066
- Equity
- DKK 13,550,280
- Total Assets
- DKK 22,046,913
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 2.4 mio. | 3.2 mio. | 13.6 mio. | 0 |
| 2021 | - | 1.8 mio. | 1.6 mio. | 10.4 mio. | 0 |
| 2020 | - | 1.5 mio. | 1.7 mio. | 8.8 mio. | - |
| 2019 | - | 2 mio. | 1.5 mio. | 7.1 mio. | - |
| 2018 | - | 1.3 mio. | 954 t. | 5.6 mio. | - |
Official annual report
Keep an eye on BIOLIT ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout BIOLIT ApS
BIOLIT ApS is a Danish company of the type Anpartsselskab based in Fredensborg, founded in 2001. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Flemming Velin. The board consists of Thomas Velin (chair), Flemming Velin and Majken Velin. The company is owned by SCANVET ANIMAL HEALTH A/S. The company has 3 employees (2006). In 2025, the company reported a gross profit of DKK 125,902 and a net result of DKK -20,616,619 compared with DKK 13,041,006 the year before. Equity in the 2025 report amounted to DKK 10,762,624.